Page 145 - Tata_Chemicals_yearly-reports-2017-18
P. 145
6WDWHPHQW RI &DVK )ORZV IRU WKH \HDU HQGHG 0DUFK
` in crore
Particulars Year ended Year ended
31 March, 2018 31 March, 2017
A Cash flows from operating activities
Profit before tax from continuing operations 903.59 804.01
Profit before tax from discontinued operation 1,651.71 185.59
2,555.30 989.60
Adjustments for :
Depreciation and amortisation expense 139.13 169.88
Impairment of assets (note 31) 65.40 - Integrated Report
Finance costs 149.92 276.66
Interest income (14.11) (3.01)
Dividend income (101.98) (105.32)
Profit on sale of discontinued operation (note 31) (1,279.39) -
Net gain on sale of current investments (49.54) (2.30)
Provision for employee benefits expense (2.74) 28.06
Provision for doubtful debts and advances/bad debts written off/(back) 46.15 (1.18)
Provision for contingencies 10.23 17.96
Liabilities no longer required written back (19.17) (6.19)
Realised foreign exchange loss due to financing activities 3.87 69.41
Unrealised foreign exchange (gain)/loss (net) (0.31) 1.36
Loss on assets sold or discarded (net) 7.38 2.15
Operating profit before working capital changes 1,510.14 1,437.08 Statutory Reports
Adjustments for :
Trade receivables, other financial assets and other assets (74.28) 981.19
Inventories 110.24 356.89
Trade payables, other financial liabilities and other liabilities 37.79 (72.26)
Cash generated from operations 1,583.89 2,702.90
Taxes paid (net of refund) (747.51) (309.49)
Net cash generated from operating activities 836.38 2,393.41
B Cash flows from investing activities
Acquisition of property, plant and equipment (including capital work-in-progress) (328.74) (264.81)
Acquisition of intangible assets (including intangible asset under development) (1.16) (2.42)
Proceeds from sale of property, plant and equipment 12.56 1.62
Proceeds from sale of other non-current investments 920.07 5.19
Proceeds from sale of current investments 14,708.51 10,669.18 Financial Statements
Purchase of non-current investments (36.77) (0.50)
Purchase of current investments (14,658.98) (10,669.18)
Investment in subsidiary (0.05) -
Bank balances not considered as cash and cash equivalent (450.00) -
Proceeds from sale of discontinued operations (net) (note 31) 2,593.98 -
Interest received 4.62 3.96
Dividend received
- From subsidiaries 36.50 24.34
- From joint venture 9.82 21.02
- From others 55.66 59.96
Net cash from/(used in) in investing activities 2,866.02 (151.64)
Standalone Financial Statements 143